Arkolith/Insider Trading/IRWD/Form 4

Silver Ronald

Principal Accounting OfficerIRONWOOD PHARMACEUTICALS INC (IRWD) · full profile →Form 4 · filed Feb 25, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$90K
Net Open-Market Flow
-$90K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 24, 2026Sell(S)13K$3.66$46K253K
Feb 23, 2026Sell(S)12K$3.81$44K265K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-071495) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML